[Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents]

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Clinical evidence shows cholesterol reduction benefits atherosclerotic vascular disease prevention.
• Current understanding attributes benefits to reduced LDL leading to plaque regression.
• Alternative mechanisms like plaque stabilization and improved endothelial function are proposed.

Purpose of the Study:

• To review mechanisms of cholesterol-lowering interventions in atherosclerotic vascular disease.
• To discuss direct effects of cholesterol-lowering agents on endothelial function, independent of LDL reduction.

Main Methods:

• Literature review of clinical evidence and proposed mechanisms.
• Discussion of pharmacological actions of cholesterol-lowering agents, particularly statins.

Main Results:

• Cholesterol reduction positively impacts cardiovascular outcomes.
• Mechanisms include decreased plaque progression/regression and potential plaque stabilization.
• Direct effects of statins on endothelial function are hypothesized.

Conclusions:

• Cholesterol-lowering interventions offer significant benefits in atherosclerotic vascular disease.
• Mechanisms extend beyond LDL reduction, involving plaque stabilization and endothelial health.
• Further investigation into direct pharmacological effects of agents like statins is warranted.